MicroTransponder announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.
Data highlighted Vivistim’s impact when paired with occupational or physical therapy to...
Wellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, ‘Axana’ 0.1T, for stroke identification in...
ScreenPoint Medical has demonstrated the value of its AI-powered Transpara: Breast AI screening tool in a new study.
The Netherlands-based company’s Mammography Screening with Artificial...
Wandercraft kicked off a landmark clinical trial for its Personal Exoskeleton technology. The device aims to offer upright motion and walking independence for individuals...
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the...
Movano Health announced that it commenced a blood pressure clinical trial with its new cuffless wrist wearable.
Pleasanton, California-based Movano designed its updated device to...
Median Technologies announced that eyonis™ LCS, its wholly owned proprietary AI/ML-based CADe/CADx Software as a Medical Device (SaMD) for lung cancer screening, met the...
US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer trial.
Designed for subjects with solid tumours, the...
BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new studies.
The French company’s AI software received 510(k) clearance...
